BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24341820)

  • 21. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial.
    Manzano S; Bailey B; Girodias JB; Galetto-Lacour A; Cousineau J; Delvin E
    Am J Emerg Med; 2010 Jul; 28(6):647-53. PubMed ID: 20637377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
    Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.
    Tang H; Huang T; Jing J; Shen H; Cui W
    Infection; 2009 Dec; 37(6):497-507. PubMed ID: 19826761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial.
    Baer G; Baumann P; Buettcher M; Heininger U; Berthet G; Schäfer J; Bucher HC; Trachsel D; Schneider J; Gambon M; Reppucci D; Bonhoeffer JM; Stähelin-Massik J; Schuetz P; Mueller B; Szinnai G; Schaad UB; Bonhoeffer J
    PLoS One; 2013; 8(8):e68419. PubMed ID: 23936304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
    Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
    Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.
    Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schroeder S
    Crit Care; 2009; 13(3):R83. PubMed ID: 19493352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.
    Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Baechli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Schuetz P; Gaillat J; Regez K; Bossart R; Schild U; Müller B; Albrich WC;
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):51-60. PubMed ID: 22886090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient].
    Long W; Deng XQ; Tang JG; Xie J; Zhang YC; Zhang Y; Gao YY; Lu G
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):216-9. PubMed ID: 19576090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671].
    Briel M; Christ-Crain M; Young J; Schuetz P; Huber P; Périat P; Bucher HC; Müller B
    BMC Fam Pract; 2005 Aug; 6():34. PubMed ID: 16107222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.
    Kristoffersen KB; Søgaard OS; Wejse C; Black FT; Greve T; Tarp B; Storgaard M; Sodemann M
    Clin Microbiol Infect; 2009 May; 15(5):481-7. PubMed ID: 19416298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.
    Deliberato RO; Marra AR; Sanches PR; Martino MD; Ferreira CE; Pasternak J; Paes AT; Pinto LM; dos Santos OF; Edmond MB
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):266-71. PubMed ID: 23711530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.
    Hohn A; Schroeder S; Gehrt A; Bernhardt K; Bein B; Wegscheider K; Hochreiter M
    BMC Infect Dis; 2013 Apr; 13():158. PubMed ID: 23547790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
    Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR
    J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
    Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
    APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procalcitonin-guided therapy for the initiation of antibiotics in the ED: a systematic review.
    van der Does Y; Rood PP; Haagsma JA; Patka P; van Gorp EC; Limper M
    Am J Emerg Med; 2016 Jul; 34(7):1286-93. PubMed ID: 27130585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.
    Qu J; L X; Liu Y; Wang X
    Indian J Med Res; 2015 Mar; 141(3):315-21. PubMed ID: 25963492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy].
    Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schröder S
    Anaesthesist; 2008 Jun; 57(6):571-7. PubMed ID: 18463831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.